What was it about the COVID-19 virus that made it spread rapidly through the population and cause disease on a greater scale than other SARS related coronaviruses?Question 11AnswerMutations in the spike protein allowed it to specifically interact with the ACE2 receptor on lung cells. Also, the correct positioning of basic amino acids within the spike protein which could be cleaved was vital.Mutations in the spike protein allowed it to specifically interact with the ACE2 receptor on lung cellsThe correct positioning of basic amino acids in the spike protein which could be cleavedMutations in the spike protein allowed it to specifically interact with the ACE2 receptor on lung cells. Also, the correct positioning of acidic amino acids in the spike protein which could be cleaved was vita

The coronavirus disease 2019 (COVID-19) pandemic challenged the work-ings of human society, but in doing so, it advanced our understanding ofthe ecology and evolution of infectious diseases. Fluctuating transmissionof severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demon-strated the highly dynamic nature of human social behavior, often withoutgovernment intervention. Evolution of SARS-CoV-2 in the first two yearsfollowing spillover resulted primarily in increased transmissibility, while inthe third year, the globally dominant virus variants had all evolved substantialimmune evasion. The combination of viral evolution and the buildup of hostimmunity through vaccination and infection greatly decreased the realizedvirulence of SARS-CoV-2 due to the age dependence of disease severity. TheCOVID-19 pandemic was exacerbated by presymptomatic, asymptomatic,and highly heterogeneous transmission, as well as highly variable diseaseseverity and the broad host range of SARS-CoV-2. Insights and tools de-veloped during the COVID-19 pandemic could provide a stronger scientificbasis for preventing, mitigating, and controlling future pandemics.

One type of COVID-19 vaccine, developed by both Pfizer BioNTech and Moderna, consists of coding for the spike protein of SARS-CoV-2 encased in a lipid envelope.

The disease COVID-19 is caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2). The virus was first identified at the beginning of 2020, and has since gone on to cause a pandemic. It is currently believed that SARS-CoV-2 is an example of a zoonosis.Throughout 2020, much of the world’s medical scientific community was devoted to developing a vaccine for SARS-CoV-2. To evaluate the effectiveness of new vaccines, both humoral and cell-mediated responses are measured in animal subjects. Identify the cell type that is involved in both responses, and explain its role in each.

Which coronavirus protein is responsible for attaching the virus to the receptors on the host cell's membrane?Multiple ChoiceM proteinH proteinS proteinE protein

Monoclonal antibodies (mAbs) neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were the first antiviral drugs specifically developed for the treatment and prophylaxis of coronavirus disease 2019 (COVID-19) (1). Emergence of variants of concern (VOC) resistant to such antibodies on population level, however, limits their broad applicability. The Omicron variants, for example, are only neutralized by a small subset of monoclonal antibodies developed for the treatment of SARS-CoV-2 infections (2, 3). As more variants emerge, having a repertoire of monoclonal antibodies targeting different sites of the Spike protein may become useful. Therefore, we explored the prophylactic efficacy of two monoclonal antibodies targeting the receptor binding domain (RBD) of SARS-CoV-2 in a nonhuman primate model of SARS-CoV-2 infection. We additionally investigated their genetic barrier to resistance in vivo and in vitro.